Deep Learning Signature for Predicting Complete Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer
Clinical trial NCT05925751 · UNKNOWN
Trial details
- NCT number
- NCT05925751
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-01
- Primary completion
- 2023-10-31
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.